Literature DB >> 22688772

Antigen presentation assays to investigate uncharacterized immunoregulatory genes.

Rachel L Roper1.   

Abstract

Antigen presentation to T lymphocytes is the seminal triggering event of the specific immune response, and poxviruses encode immunomodulatory genes that disrupt this process. Discovery of viral proteins that interfere with steps in the antigen presentation process requires a robust, easily manipulated antigen-presenting and T lymphocyte response system. Use of fresh primary antigen-presenting cells (APC) is preferable because cell lines that can present antigen in vitro are often not representative of APC in vivo and are typically weak stimulators. To study immunomodulatory poxvirus genes, we have used infected primary rat macrophages to present a model antigen, the myelin basic protein peptide, to a cognate CD4+ RsL11 T cell clone. Using this system, viruses can be assessed for difference in immunomodulation, and viral gene functions may also be assayed by comparing effects of wild type virus and mutant viruses (e.g., a deletion in the putative immunomodulatory gene). While antigen presentation can be thought of as a single event, it can also be considered as a larger process comprising multiple steps including: antigen acquisition, antigen processing, peptide loading onto MHC molecules, transport to the surface, MHC binding to T cell receptor, interaction of costimulatory molecules, cell signaling, cytokine synthesis by both cells, and proliferation of antigen specific T lymphocytes. This system allows for the initial determination of whether there is a phenotype and then also allows the stepwise deconstruction of the system to analyze this process at several points to focus in on the mechanism of immunomodulation. We have used this model system to elucidate the function of a highly conserved but previously uncharacterized poxvirus gene that we showed was important for virulence in rodents. The experimental system developed should be broadly applicable to analyzing viral effects on immunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22688772      PMCID: PMC4196709          DOI: 10.1007/978-1-61779-876-4_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

1.  The MC160 protein expressed by the dermatotropic poxvirus molluscum contagiosum virus prevents tumor necrosis factor alpha-induced NF-kappaB activation via inhibition of I kappa kinase complex formation.

Authors:  Daniel Brian Nichols; Joanna L Shisler
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  The poxvirus A35 protein is an immunoregulator.

Authors:  Kristina E Rehm; Gwendolyn J B Jones; Alice A Tripp; Mark W Metcalf; Rachel L Roper
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

3.  MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4- responders.

Authors:  M D Mannie; M S Norris
Journal:  Cell Immunol       Date:  2001-08-25       Impact factor: 4.868

4.  Disruption of MHC class II-restricted antigen presentation by vaccinia virus.

Authors:  Ping Li; Nan Wang; Delu Zhou; Christina S K Yee; Cheong-Hee Chang; Randy R Brutkiewicz; Janice S Blum
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

5.  Characterization of the vaccinia virus A35R protein and its role in virulence.

Authors:  Rachel L Roper
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein.

Authors:  Ritu R Bradley; Masanori Terajima
Journal:  Virus Res       Date:  2005-07-20       Impact factor: 3.303

7.  The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range.

Authors:  Jeffrey O Langland; Bertram L Jacobs
Journal:  Virology       Date:  2002-07-20       Impact factor: 3.616

8.  Vaccinia virus A35R inhibits MHC class II antigen presentation.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Rachel L Roper
Journal:  Virology       Date:  2009-12-02       Impact factor: 3.616

9.  Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Mark D Mannie; Rachel L Roper
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

10.  Cowpox virus transmission from rats to monkeys, the Netherlands.

Authors:  Byron E E Martina; Gerard van Doornum; Gerry M Dorrestein; Hubert G M Niesters; Koert J Stittelaar; Marno A B I Wolters; Hester G H van Bolhuis; Albert D M E Osterhaus
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

View more
  1 in total

1.  Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.

Authors:  Michael White; Andrew Freistaedter; Gwendolyn J B Jones; Emmanuel Zervos; Rachel L Roper
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.